Cargando…

A summary of current NKG2D-based CAR clinical trials

Cancer immunotherapies have significantly improved patient survival and treatment options in recent years. Nonetheless, the success of immunotherapy is limited to certain cancer types and specific subgroups of patients, making the development of new therapeutic approaches a topic of ongoing research...

Descripción completa

Detalles Bibliográficos
Autores principales: Curio, Sophie, Jonsson, Gustav, Marinović, Sonja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480431/
https://www.ncbi.nlm.nih.gov/pubmed/34604863
http://dx.doi.org/10.1093/immadv/ltab018